Ocugen Inc Stock Ownership - Who owns Ocugen?

Insider buying vs selling

Have Ocugen Inc insiders been buying or selling?
Arun UpadhyayChief Scientific Officer Head of Research Development and Medical2024-06-17917$1.42
Shankar MusunuriChief Executive Officer2024-01-03180,204$0.65
Arun UpadhyayChief Scientific Officer Head of Research Development and Medical2024-01-0341,633$0.65
Arun UpadhyayChief Scientific Officer Head of Research Development and Medical2023-09-16842$0.41

1 of 1

OCGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCGN insiders and whales buy or sell their stock.

OCGN Shareholders

What type of owners hold Ocugen Inc stock?
Vanguard Group Inc4.66%11,999,551$22.08MInstitution
Michael 1. Lewis2.16%5,548,103$10.21MInsider
Wilmslow Estates Ltd2.04%5,258,859$9.68MInsider
Randal J. Kirk1.70%4,382,936$8.06MInsider
Shankar Musunuri1.67%4,300,467$7.91MInsider
Blackrock Inc1.48%3,799,240$6.99MInstitution
Geode Capital Management LLC1.25%3,213,520$5.91MInstitution
Split Rock Partners Ii LP1.08%2,775,538$5.11MInsider
Goldman Sachs Group Inc1.01%2,607,625$4.80MInstitution
Junge Zhang0.88%2,254,949$4.15MInsider

1 of 3

OCGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCGN12.76%11.93%Net SellingNet Selling
LXRX19.61%80.39%Net Buying
HRTX50.06%49.94%Net BuyingNet Selling
VYGR54.30%45.70%Net Selling
ALLO62.79%37.21%Net BuyingNet Buying

Ocugen Stock Ownership FAQ

Who owns Ocugen?

Ocugen (NASDAQ: OCGN) is owned by 12.76% institutional shareholders, 11.93% Ocugen insiders, and 75.31% retail investors. Michael 1. Lewis is the largest individual Ocugen shareholder, owning 5.55M shares representing 2.16% of the company. Michael 1. Lewis's Ocugen shares are currently valued at $10.43M.

If you're new to stock investing, here's how to buy Ocugen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.